Men's Health News

RSS

EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.

3 Nov 2010

AHRQ study finds prostate cancer mortality rate declines by 45%

According to the U.S. Agency for Healthcare Research and Quality (AHRQ), compared to men in 1999, American men in 2006 that were fighting prostate cancer were 45% less likely to die from the disease.

3 Nov 2010

Image Guided IMRT preserves sexual function in men after prostatectomy

Men battling prostate cancer who receive Image Guided Intensity Modulated Radiation Therapy after undergoing prostatectomy have an excellent chance of retaining sexual function, according to a study by Allegheny General Hospital (AGH) cancer specialists presented this week at the annual meeting of the American Society for Therapeutic Radiation and Oncology in San Diego.

3 Nov 2010

Staff member of U.S. preventive services task force quits over cancelled meeting

A member of the support staff for the United States Preventive Services Task Force has quit over the cancellation of a meeting scheduled for today and tomorrow at which the task force was due to vote on the controversial issue of prostate-cancer screening.

3 Nov 2010

$Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients$

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

When treating prostate cancer with radiation therapy, side effects such as urinary problems and rectal pain and bleeding are a concern, as is impact on the patient's overall quality of life. So when new, more efficient treatment methods are developed, one important question is whether better treatment comes at the cost of increased side effects and decreased quality of life.

2 Nov 2010

Calypso Medical to showcase FDA cleared Dynamic Edge Gating Technology at 52nd ASTRO

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced it will showcase Dynamic Edge™ Gating Technology, recently cleared by the U.S. Food and Drug Administration, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), now underway at the San Diego Convention Center.

1 Nov 2010

Dance for the Cure of Prostate Cancer: A national awareness and fundraising campaign

Today, AdMeTech Foundation in cooperation with Nick Kosovich of Dancing with the Stars, Arthur Murray International (AMI), Philips Healthcare, Mary Murphy of Fox TV Hit So You Think You Can Dance and other key leaders of the dancing community have launched Dance for the Cure of Prostate Cancer as a national awareness and fundraising campaign to end the prostate cancer crisis.

30 Oct 2010

Karmanos, WSU SOM present long-term results of fast neutron radiotherapy in localized prostate cancer

Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting

30 Oct 2010

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

An endocrinologist in the University at Buffalo's School of Medicine and Biomedical Sciences has received a three-year $400,000 Junior Faculty Award from the American Diabetes Society to study the effects of low testosterone levels in young men with type 2 diabetes.

30 Oct 2010

High urine BPA levels associated with decreased sperm quality

Increasing urine BPA (Bisphenol-A) level was significantly associated with decreased sperm concentration, decreased total sperm count, decreased sperm vitality and decreased sperm motility, according to a Kaiser Permanente study appearing in the journal of Fertility and Sterility.

28 Oct 2010

Experts urge clinicians to discuss sperm banking with male cancer patients

Many men whose fertility may be at risk from cancer treatment are not being offered the chance to store their sperm according to new research published today in the Annals of Oncology (Thursday).

28 Oct 2010

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 pivotal trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH).

28 Oct 2010

Taller men at increased risk of testicular cancer: Study

Taller men could be at an increased risk of testicular cancer, new research suggests.

27 Oct 2010

Scientists discover MSMB protein in urine can predict prostate cancer risk

British scientists have identified a protein in urine that can help indicate which patients are at an increased risk of developing prostate cancer. The Cancer Research UK Cambridge Research Institute and The Institute of Cancer Research found that the level of MSMB protein in urine could provide a fast and accurate prostate cancer diagnosis for doctors and patients, potentially replacing the currently painful and more costly approach a blood sample.

27 Oct 2010

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

A new British review of existing research suggests that while a newer type of radiation for the treatment of prostate cancer does not help patients live longer compared to an older type at least when similar doses are given it does appear to reduce gastrointestinal side effects.

27 Oct 2010

PSA test helps detect prostate cancer before it spreads

In addition to saving lives, a new study indicates routine prostate-specific antigen (PSA) testing improves quality of life by substantially reducing the risk that prostate cancer will spread to other parts of the body.

27 Oct 2010

U.S. Preventative Services Task Force cancels meeting to review prostate-cancer screening

The Wall Street Journal Health Blog: "The United States Preventive Services Task Force has canceled a meeting set for early next month at which the thorny issue of prostate-cancer screening was due for a vote. ... [W]hen prostate-cancer screening came up last fall, the USPSTF initially voted to recommend against screening for men of all ages before opting instead to re-vote on the issue.

27 Oct 2010

IMRT reduces gastrointestinal complications in prostate cancer patients

Prostate cancer patients who receive intensity modulated radiation therapy (IMRT) are less apt to suffer serious gastrointestinal complications following their treatment than those who receive three-dimensional conformal radiotherapy (CRT), according to new research from the University of Pennsylvania School of Medicine.

27 Oct 2010

Sex hormones behind increased risk of destructive periodontitis in men

Sex hormones may be the biological reason why men are at greater risk than women for destructive periodontitis, an infection of the gums, according to researchers at the University of Maryland Dental School.

27 Oct 2010

First step in development of artificial human testicle

After more than 30 years of unsuccessful efforts by numerous investigators, researchers have now found a way to propagate primary human Sertoli cells in the laboratory. Derived from the testis, it has been difficult to maintain Sertoli cells, the "nurse" cells responsible for overseeing sperm production, outside of the human body.

26 Oct 2010

Men's Health News

EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society

AHRQ study finds prostate cancer mortality rate declines by 45%

Image Guided IMRT preserves sexual function in men after prostatectomy

Staff member of U.S. preventive services task force quits over cancelled meeting

Hypofractionated IMRT therapy does not increase side effects in prostate cancer patients

Calypso Medical to showcase FDA cleared Dynamic Edge Gating Technology at 52nd ASTRO

Dance for the Cure of Prostate Cancer: A national awareness and fundraising campaign

Karmanos, WSU SOM present long-term results of fast neutron radiotherapy in localized prostate cancer

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

High urine BPA levels associated with decreased sperm quality

Experts urge clinicians to discuss sperm banking with male cancer patients

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Taller men at increased risk of testicular cancer: Study

Scientists discover MSMB protein in urine can predict prostate cancer risk

New type of radiation reduces GI side effects but does not improve survival rate in prostate cancer patients

PSA test helps detect prostate cancer before it spreads

U.S. Preventative Services Task Force cancels meeting to review prostate-cancer screening

IMRT reduces gastrointestinal complications in prostate cancer patients

Sex hormones behind increased risk of destructive periodontitis in men

First step in development of artificial human testicle

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News